StonvexLoading…
StonvexStonvexStonvexCore line items from EXP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $1.83B | $1.27B | $634.69M | $2.26B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $363.65M | $137.38M | $123.36M | $463.42M |
EPS (Diluted) | $11.21 | $7.99 | $3.76 | $13.77 |
Total Assets | $3.84B | $3.41B | $3.40B | $3.26B |
Total Liabilities | $2.35B | $1.87B | $1.91B | $1.81B |
Cash & Equivalents | $419.00M | $35.03M | $59.74M | $20.40M |
Free Cash Flow OCF − CapEx | $217.35M | $156.60M | $60.54M | $353.27M |
Shares Outstanding | 31.55M | 32.20M | 32.58M | 32.97M |